September 4, 2001
Emory 7th busiest in kidney transplants
By Holly Korschun
Emory Hospital is the nations seventh-busiest in kidney-pancreas transplants, according to a recent survey by U.S. News & World Report. Emory physicians performed 22 kidney-pancreas transplants in 2000.
This is the first year U.S. News has featured transplants in its
annual Best Hospitals issue. In the same issue, Emory Hospital
was named one of Americas best in five medical specialties: cardiology
(ninth), ophthalmology (ninth), kidney disease (18th), gynecology (40th)
and urology (41st).
This year our number of transplants is considerably higher, and
we expect to perform between 32 and 35 kidney-pancreas transplants in
2001, said Christian Larsen, co-director of Emorys kidney
transplantation program along with Thomas Pearson.
The kidney program has gained an international reputation for groundbreaking
research leading to new strategies to stop rejection of transplanted organs.
Emory was selected in 1999 to be part of the Collaborative Network for
Clinical Research on Immune Tolerance, a nationwide network of 39 institutions
in nine countries to conduct clinical trials using new research strategies
to improve organ transplantation.
Larsen, who recently was named director of the Emory Transplant Center,
was selected to lead the kidney transplant trials group for the new nationwide
network, which is funded by the National Institute of Allergy and Infectious
Diseases, the National Institute of Diabetes and Digestive and Kidney
Diseases and the Juvenile Diabetes Foundation. In 1998 the NIH awarded
physician-researchers in Emorys Center for Transplantation a five-year,
$7.5 million grant to help establish true immune tolerance in patients
receiving organ transplants.
Key to the growth of the transplant center has been the ongoing support
of the Carlos and Marguerite Mason Trust of Atlanta, as well as the support
of the Livingston Foundation and the Woodruff Fund.
Emorys program in kidney-pancreas transplantation continues to make great strides, both in numbers of transplants and success of our transplant strategy, Larsen said.